Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
gabapentin
Sun Pharma ANZ Pty Ltd
Gabapentin
Tablet, film coated
Excipient Ingredients: hyprolose; mannitol; crospovidone; purified talc; magnesium stearate; poloxamer; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; Shellac; sulfuric acid
Oral
50 tablets, 100 tablets
(S4) Prescription Only Medicine
GABARAN is indicated for the maintenance treatment of, partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs. GABARAN is also indicated for the maintenance treatment of neuropathic pain
Visual Identification: White to off-white, oval shaped, biconvex, film-coated tablets imprinted with 'G 800' in black ink on one side and plain on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Registered
2007-05-02
Gabaran CMI V11 Jan09 Page 1 of 8 GABARAN ® GABAPENTIN_ _600MG/800MG TABLETS CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about GABARAN TABLETS (gabapentin). It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking GABARAN against the benefits it is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT USING/TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THIS MEDICINE. You may need to read it again. WHAT GABARAN TABLET IS USED FOR GABARAN contains gabapentin. Gabapentin belongs to a group of medicines used for treating epilepsy (antiepileptic medicines). These drugs are thought to work by controlling brain chemicals, which send signals to nerves so that convulsions do not happen. Gabapentin also has analgesic effects. It may also be used for treating neuropathic pain (pain caused by damage to nerves). Your doctor would have prescribed GABARAN tablets for one or more of the following: To treat certain types of epilepsy (partial onset seizures) in combination with other antiepileptic medicines, when the condition is not controlled with other anti-epileptic medicines or there are unacceptable side effects. To treat neuropathic pain (pain caused by damage to nerves). A variety of conditions can cause neuropathic pain, e.g., shingles, diabetes, trauma. GABARAN 600 mg and 800 mg tablets will not be used to start your treatment. Your doctor will give you another brand of gabapentin when you begin your treatment. You will be given GABARAN tablets once your daily dose of gabapentin is 1800 mg (one 600 mg tablet three times a day) or more than 1800 mg. Your doctor may have prescribed GABARAN tablets for another reason. Ask your doctor if you have any questions about why GABARAN tablets have been prescribed for you. There is no evidence that GABARAN tablets are addictive. Gabapentin may Read the complete document
GABARAN PI V10 JAN 2009 Page 1 of 16 GABARAN 600MG / 800MG TABLETS (GABAPENTIN TABLETS) NAME OF THE MEDICINE Gabapentin _CAS Number_:_ _60142-96-3 DESCRIPTION GABARAN tablets contain gabapentin, which is chemically designated as 1-(aminomethyl) cyclohexaneacetic acid, with a molecular formula of C 9 H 17 NO 2 and a molecular weight of 171.24. Gabapentin is a white to off-white crystalline solid with a pKa 1 of 3.7 and a pKa 2 of 10.7. It is freely soluble in water and both basic and acidic aqueous solutions. The log of the partition coefficient (n-octanol/0.05M phosphate buffer) at pH 7.4 is –1.25. GABAPENTIN STRUCTURE GABARAN tablets contain following inactive ingredients: hydroxypropylcellulose, mannitol, crospovidone, purified talc, magnesium stearate, poloxamer, Opadry 20A59015, OPACODE S-1- 17823. PHARMACOLOGY MECHANISM OF ACTION The mechanism by which gabapentin exerts its anticonvulsant action is unknown. Gabapentin is structurally related to the neurotransmitter GABA (gamma-aminobutyric acid) but its mechanism of action is different from that of several other drugs that interact with GABA synapses including valproate, barbiturates, benzodiazepines, GABA transaminase inhibitors, GABA uptake inhibitors, GABA agonists, and GABA prodrugs. _In _ _vitro_ studies with radiolabelled gabapentin have characterised a novel peptide-binding site in rat brain tissues including neocortex and hippocampus that may relate to anticonvulsant activity of gabapentin GABARAN PI V10 JAN 2009 Page 2 of 16 and its structural derivatives. However, the identification and function of the gabapentin binding site remains to be elucidated. Gabapentin at relevant clinical concentrations does not bind to other common drug or neurotransmitter receptors of the brain including GABA A , GABA B , benzodiazepine, glutamate, glycine or N-methyl-d-aspartate receptors. Gabapentin does not interact with sodium channels in vitro and so differs from phenytoin and carbamazepine. Several test systems ordinarily used to assess activity at the NMDA rec Read the complete document